Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Irbesartan in hypertensive patients with left ventricular hypertrophy.

Trial Profile

Irbesartan in hypertensive patients with left ventricular hypertrophy.

Phase of Trial: Phase IV

Latest Information Update: 27 May 2011

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms I-SELECT
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Dec 2008 Planned number of patients changed from 418 to 268 as reported by ClinicalTrials.gov.
    • 10 Apr 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top